Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Corvus Pharmaceuticals Inc buy Cantor Fitzgerald

Start price
€7.33
16:15 / 50%
Target price
-
11.12.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 11.12.26. The prediction end date can be changed by Cantor_Fitzgerald at any time.
Performance without dividends (%)
Name 1w
Corvus Pharmaceuticals Inc -
iShares Core DAX® 1.803%
iShares Nasdaq 100 0.429%
iShares Nikkei 225® 0.708%
iShares S&P 500 0.288%

Comments by Cantor_Fitzgerald for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren

Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for CRVS provided by MarketBeat

Stopped prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc

buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.67
01.04.24
-
01.04.25
71.74%
02.04.25

buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.51
07.09.23
€3.74
07.09.24
146.36%
08.09.24